Q2 FY26 results: standalone loss on subsidiary impairment, consolidated PAT up 50%
EIDPARRY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 1.4 pts less than its Other Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q2/H1 FY26 unaudited results. Standalone Q2 loss after tax Rs 28,562 lakhs, EPS negative Rs 16.06, hit by Rs 35,223 lakhs exceptional impairment in subsidiary PSRIPL. Standalone H1 loss Rs 31,354 lakhs. Consolidated strong: Q2 revenue up 24.6 percent YoY at Rs 11,62,444 lakhs, PAT up 29.5 percent at Rs 76,616 lakhs. H1 PAT up 50.5 percent to Rs 1,23,062 lakhs. Limited review by Price Waterhouse was clean.
Standalone loss is largely a one-time subsidiary impairment. Consolidated earnings grew strongly led by Coromandel subsidiary performance.